ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global CNS Specific Antisense Oligonucleotides Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-13T6048
Home | Market Reports | Science| Biological Sciences
Global CNS Specific Antisense Oligonucleotides Market Insights Forecast to 2028
BUY CHAPTERS

Global CNS Specific Antisense Oligonucleotides Market Research Report 2025

Code: QYRE-Auto-13T6048
Report
July 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Akcea Therapeutics Inc
Ionis Pharmaceuticals Inc
Biogen
Sarepta Therapeutics
WAVE Life Sciences Ltd
Dynacure
ProQR Therapeutics N.V.
Stroke Therapeutic Inc.

CNS Specific Antisense Oligonucleotides Market

The global market for CNS Specific Antisense Oligonucleotides was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Antisense oligonucleotides are single-stranded oligodeoxynucleotides that can alter the RNA and modify protein expression. These oligonucleotides were discovered to influence RNA processing. Subsequent chemical modifications of antisense oligonucleotides were used to address issues such as off-target toxic effects and insufficient biological activity. These modifications led to an improved mechanism of antisense oligonucleotides and clinical trial design. This paved the way toward translating their use into therapies for various genetic and neurological conditions. Antisense oligonucleotides mediated therapies target the source of pathogenesis and have higher chance of success as compared to therapies that target downstream pathways. These are drugs for the treatment of central nervous system (CNS) disorders, as they have specific molecular targeting and extended pharmacological properties.
North American market for CNS Specific Antisense Oligonucleotides is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for CNS Specific Antisense Oligonucleotides is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for CNS Specific Antisense Oligonucleotides in Hospital Pharmacies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of CNS Specific Antisense Oligonucleotides include Akcea Therapeutics, Inc., Ionis Pharmaceuticals Inc., Biogen Inc., Sarepta Therapeutics, Wave Life Sciences Ltd., Dynacure, ProQR Therapeutics N.V., Stroke Therapeutic Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CNS Specific Antisense Oligonucleotides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CNS Specific Antisense Oligonucleotides.
The CNS Specific Antisense Oligonucleotides market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CNS Specific Antisense Oligonucleotides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CNS Specific Antisense Oligonucleotides companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of CNS Specific Antisense Oligonucleotides Market Report

Report Metric Details
Report Name CNS Specific Antisense Oligonucleotides Market
Segment by Type
  • Polyneuropathy Treatment
  • Spinal Muscular Atrophy (SMA) Treatment
  • Huntington’s Disease Treatment
Segment by Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Akcea Therapeutics, Inc., Ionis Pharmaceuticals Inc., Biogen Inc., Sarepta Therapeutics, Wave Life Sciences Ltd., Dynacure, ProQR Therapeutics N.V., Stroke Therapeutic Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of CNS Specific Antisense Oligonucleotides company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the CNS Specific Antisense Oligonucleotides Market report?

Ans: The main players in the CNS Specific Antisense Oligonucleotides Market are Akcea Therapeutics, Inc., Ionis Pharmaceuticals Inc., Biogen Inc., Sarepta Therapeutics, Wave Life Sciences Ltd., Dynacure, ProQR Therapeutics N.V., Stroke Therapeutic Inc.

What are the Application segmentation covered in the CNS Specific Antisense Oligonucleotides Market report?

Ans: The Applications covered in the CNS Specific Antisense Oligonucleotides Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the CNS Specific Antisense Oligonucleotides Market report?

Ans: The Types covered in the CNS Specific Antisense Oligonucleotides Market report are Polyneuropathy Treatment, Spinal Muscular Atrophy (SMA) Treatment, Huntington’s Disease Treatment

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CNS Specific Antisense Oligonucleotides Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Polyneuropathy Treatment
1.2.3 Spinal Muscular Atrophy (SMA) Treatment
1.2.4 Huntington’s Disease Treatment
1.3 Market by Application
1.3.1 Global CNS Specific Antisense Oligonucleotides Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CNS Specific Antisense Oligonucleotides Market Perspective (2020-2031)
2.2 Global CNS Specific Antisense Oligonucleotides Growth Trends by Region
2.2.1 Global CNS Specific Antisense Oligonucleotides Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CNS Specific Antisense Oligonucleotides Historic Market Size by Region (2020-2025)
2.2.3 CNS Specific Antisense Oligonucleotides Forecasted Market Size by Region (2026-2031)
2.3 CNS Specific Antisense Oligonucleotides Market Dynamics
2.3.1 CNS Specific Antisense Oligonucleotides Industry Trends
2.3.2 CNS Specific Antisense Oligonucleotides Market Drivers
2.3.3 CNS Specific Antisense Oligonucleotides Market Challenges
2.3.4 CNS Specific Antisense Oligonucleotides Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CNS Specific Antisense Oligonucleotides Players by Revenue
3.1.1 Global Top CNS Specific Antisense Oligonucleotides Players by Revenue (2020-2025)
3.1.2 Global CNS Specific Antisense Oligonucleotides Revenue Market Share by Players (2020-2025)
3.2 Global CNS Specific Antisense Oligonucleotides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CNS Specific Antisense Oligonucleotides Revenue
3.4 Global CNS Specific Antisense Oligonucleotides Market Concentration Ratio
3.4.1 Global CNS Specific Antisense Oligonucleotides Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CNS Specific Antisense Oligonucleotides Revenue in 2024
3.5 Global Key Players of CNS Specific Antisense Oligonucleotides Head office and Area Served
3.6 Global Key Players of CNS Specific Antisense Oligonucleotides, Product and Application
3.7 Global Key Players of CNS Specific Antisense Oligonucleotides, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CNS Specific Antisense Oligonucleotides Breakdown Data by Type
4.1 Global CNS Specific Antisense Oligonucleotides Historic Market Size by Type (2020-2025)
4.2 Global CNS Specific Antisense Oligonucleotides Forecasted Market Size by Type (2026-2031)
5 CNS Specific Antisense Oligonucleotides Breakdown Data by Application
5.1 Global CNS Specific Antisense Oligonucleotides Historic Market Size by Application (2020-2025)
5.2 Global CNS Specific Antisense Oligonucleotides Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CNS Specific Antisense Oligonucleotides Market Size (2020-2031)
6.2 North America CNS Specific Antisense Oligonucleotides Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CNS Specific Antisense Oligonucleotides Market Size by Country (2020-2025)
6.4 North America CNS Specific Antisense Oligonucleotides Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CNS Specific Antisense Oligonucleotides Market Size (2020-2031)
7.2 Europe CNS Specific Antisense Oligonucleotides Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CNS Specific Antisense Oligonucleotides Market Size by Country (2020-2025)
7.4 Europe CNS Specific Antisense Oligonucleotides Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CNS Specific Antisense Oligonucleotides Market Size (2020-2031)
8.2 Asia-Pacific CNS Specific Antisense Oligonucleotides Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CNS Specific Antisense Oligonucleotides Market Size by Region (2020-2025)
8.4 Asia-Pacific CNS Specific Antisense Oligonucleotides Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CNS Specific Antisense Oligonucleotides Market Size (2020-2031)
9.2 Latin America CNS Specific Antisense Oligonucleotides Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CNS Specific Antisense Oligonucleotides Market Size by Country (2020-2025)
9.4 Latin America CNS Specific Antisense Oligonucleotides Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CNS Specific Antisense Oligonucleotides Market Size (2020-2031)
10.2 Middle East & Africa CNS Specific Antisense Oligonucleotides Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CNS Specific Antisense Oligonucleotides Market Size by Country (2020-2025)
10.4 Middle East & Africa CNS Specific Antisense Oligonucleotides Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Akcea Therapeutics, Inc.
11.1.1 Akcea Therapeutics, Inc. Company Details
11.1.2 Akcea Therapeutics, Inc. Business Overview
11.1.3 Akcea Therapeutics, Inc. CNS Specific Antisense Oligonucleotides Introduction
11.1.4 Akcea Therapeutics, Inc. Revenue in CNS Specific Antisense Oligonucleotides Business (2020-2025)
11.1.5 Akcea Therapeutics, Inc. Recent Development
11.2 Ionis Pharmaceuticals Inc.
11.2.1 Ionis Pharmaceuticals Inc. Company Details
11.2.2 Ionis Pharmaceuticals Inc. Business Overview
11.2.3 Ionis Pharmaceuticals Inc. CNS Specific Antisense Oligonucleotides Introduction
11.2.4 Ionis Pharmaceuticals Inc. Revenue in CNS Specific Antisense Oligonucleotides Business (2020-2025)
11.2.5 Ionis Pharmaceuticals Inc. Recent Development
11.3 Biogen Inc.
11.3.1 Biogen Inc. Company Details
11.3.2 Biogen Inc. Business Overview
11.3.3 Biogen Inc. CNS Specific Antisense Oligonucleotides Introduction
11.3.4 Biogen Inc. Revenue in CNS Specific Antisense Oligonucleotides Business (2020-2025)
11.3.5 Biogen Inc. Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Details
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics CNS Specific Antisense Oligonucleotides Introduction
11.4.4 Sarepta Therapeutics Revenue in CNS Specific Antisense Oligonucleotides Business (2020-2025)
11.4.5 Sarepta Therapeutics Recent Development
11.5 Wave Life Sciences Ltd.
11.5.1 Wave Life Sciences Ltd. Company Details
11.5.2 Wave Life Sciences Ltd. Business Overview
11.5.3 Wave Life Sciences Ltd. CNS Specific Antisense Oligonucleotides Introduction
11.5.4 Wave Life Sciences Ltd. Revenue in CNS Specific Antisense Oligonucleotides Business (2020-2025)
11.5.5 Wave Life Sciences Ltd. Recent Development
11.6 Dynacure
11.6.1 Dynacure Company Details
11.6.2 Dynacure Business Overview
11.6.3 Dynacure CNS Specific Antisense Oligonucleotides Introduction
11.6.4 Dynacure Revenue in CNS Specific Antisense Oligonucleotides Business (2020-2025)
11.6.5 Dynacure Recent Development
11.7 ProQR Therapeutics N.V.
11.7.1 ProQR Therapeutics N.V. Company Details
11.7.2 ProQR Therapeutics N.V. Business Overview
11.7.3 ProQR Therapeutics N.V. CNS Specific Antisense Oligonucleotides Introduction
11.7.4 ProQR Therapeutics N.V. Revenue in CNS Specific Antisense Oligonucleotides Business (2020-2025)
11.7.5 ProQR Therapeutics N.V. Recent Development
11.8 Stroke Therapeutic Inc.
11.8.1 Stroke Therapeutic Inc. Company Details
11.8.2 Stroke Therapeutic Inc. Business Overview
11.8.3 Stroke Therapeutic Inc. CNS Specific Antisense Oligonucleotides Introduction
11.8.4 Stroke Therapeutic Inc. Revenue in CNS Specific Antisense Oligonucleotides Business (2020-2025)
11.8.5 Stroke Therapeutic Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Akcea Therapeutics Inc
Ionis Pharmaceuticals Inc
Biogen
Sarepta Therapeutics
WAVE Life Sciences Ltd
Dynacure
ProQR Therapeutics N.V.
Stroke Therapeutic Inc.
List of Tables
 Table 1. Global CNS Specific Antisense Oligonucleotides Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Polyneuropathy Treatment
 Table 3. Key Players of Spinal Muscular Atrophy (SMA) Treatment
 Table 4. Key Players of Huntington’s Disease Treatment
 Table 5. Global CNS Specific Antisense Oligonucleotides Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global CNS Specific Antisense Oligonucleotides Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global CNS Specific Antisense Oligonucleotides Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global CNS Specific Antisense Oligonucleotides Market Share by Region (2020-2025)
 Table 9. Global CNS Specific Antisense Oligonucleotides Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global CNS Specific Antisense Oligonucleotides Market Share by Region (2026-2031)
 Table 11. CNS Specific Antisense Oligonucleotides Market Trends
 Table 12. CNS Specific Antisense Oligonucleotides Market Drivers
 Table 13. CNS Specific Antisense Oligonucleotides Market Challenges
 Table 14. CNS Specific Antisense Oligonucleotides Market Restraints
 Table 15. Global CNS Specific Antisense Oligonucleotides Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global CNS Specific Antisense Oligonucleotides Market Share by Players (2020-2025)
 Table 17. Global Top CNS Specific Antisense Oligonucleotides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CNS Specific Antisense Oligonucleotides as of 2024)
 Table 18. Ranking of Global Top CNS Specific Antisense Oligonucleotides Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by CNS Specific Antisense Oligonucleotides Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of CNS Specific Antisense Oligonucleotides, Headquarters and Area Served
 Table 21. Global Key Players of CNS Specific Antisense Oligonucleotides, Product and Application
 Table 22. Global Key Players of CNS Specific Antisense Oligonucleotides, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global CNS Specific Antisense Oligonucleotides Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global CNS Specific Antisense Oligonucleotides Revenue Market Share by Type (2020-2025)
 Table 26. Global CNS Specific Antisense Oligonucleotides Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global CNS Specific Antisense Oligonucleotides Revenue Market Share by Type (2026-2031)
 Table 28. Global CNS Specific Antisense Oligonucleotides Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global CNS Specific Antisense Oligonucleotides Revenue Market Share by Application (2020-2025)
 Table 30. Global CNS Specific Antisense Oligonucleotides Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global CNS Specific Antisense Oligonucleotides Revenue Market Share by Application (2026-2031)
 Table 32. North America CNS Specific Antisense Oligonucleotides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America CNS Specific Antisense Oligonucleotides Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America CNS Specific Antisense Oligonucleotides Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe CNS Specific Antisense Oligonucleotides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe CNS Specific Antisense Oligonucleotides Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe CNS Specific Antisense Oligonucleotides Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific CNS Specific Antisense Oligonucleotides Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific CNS Specific Antisense Oligonucleotides Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific CNS Specific Antisense Oligonucleotides Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America CNS Specific Antisense Oligonucleotides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America CNS Specific Antisense Oligonucleotides Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America CNS Specific Antisense Oligonucleotides Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa CNS Specific Antisense Oligonucleotides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa CNS Specific Antisense Oligonucleotides Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa CNS Specific Antisense Oligonucleotides Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Akcea Therapeutics, Inc. Company Details
 Table 48. Akcea Therapeutics, Inc. Business Overview
 Table 49. Akcea Therapeutics, Inc. CNS Specific Antisense Oligonucleotides Product
 Table 50. Akcea Therapeutics, Inc. Revenue in CNS Specific Antisense Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 51. Akcea Therapeutics, Inc. Recent Development
 Table 52. Ionis Pharmaceuticals Inc. Company Details
 Table 53. Ionis Pharmaceuticals Inc. Business Overview
 Table 54. Ionis Pharmaceuticals Inc. CNS Specific Antisense Oligonucleotides Product
 Table 55. Ionis Pharmaceuticals Inc. Revenue in CNS Specific Antisense Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 56. Ionis Pharmaceuticals Inc. Recent Development
 Table 57. Biogen Inc. Company Details
 Table 58. Biogen Inc. Business Overview
 Table 59. Biogen Inc. CNS Specific Antisense Oligonucleotides Product
 Table 60. Biogen Inc. Revenue in CNS Specific Antisense Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 61. Biogen Inc. Recent Development
 Table 62. Sarepta Therapeutics Company Details
 Table 63. Sarepta Therapeutics Business Overview
 Table 64. Sarepta Therapeutics CNS Specific Antisense Oligonucleotides Product
 Table 65. Sarepta Therapeutics Revenue in CNS Specific Antisense Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 66. Sarepta Therapeutics Recent Development
 Table 67. Wave Life Sciences Ltd. Company Details
 Table 68. Wave Life Sciences Ltd. Business Overview
 Table 69. Wave Life Sciences Ltd. CNS Specific Antisense Oligonucleotides Product
 Table 70. Wave Life Sciences Ltd. Revenue in CNS Specific Antisense Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 71. Wave Life Sciences Ltd. Recent Development
 Table 72. Dynacure Company Details
 Table 73. Dynacure Business Overview
 Table 74. Dynacure CNS Specific Antisense Oligonucleotides Product
 Table 75. Dynacure Revenue in CNS Specific Antisense Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 76. Dynacure Recent Development
 Table 77. ProQR Therapeutics N.V. Company Details
 Table 78. ProQR Therapeutics N.V. Business Overview
 Table 79. ProQR Therapeutics N.V. CNS Specific Antisense Oligonucleotides Product
 Table 80. ProQR Therapeutics N.V. Revenue in CNS Specific Antisense Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 81. ProQR Therapeutics N.V. Recent Development
 Table 82. Stroke Therapeutic Inc. Company Details
 Table 83. Stroke Therapeutic Inc. Business Overview
 Table 84. Stroke Therapeutic Inc. CNS Specific Antisense Oligonucleotides Product
 Table 85. Stroke Therapeutic Inc. Revenue in CNS Specific Antisense Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 86. Stroke Therapeutic Inc. Recent Development
 Table 87. Research Programs/Design for This Report
 Table 88. Key Data Information from Secondary Sources
 Table 89. Key Data Information from Primary Sources
 Table 90. Authors List of This Report


List of Figures
 Figure 1. CNS Specific Antisense Oligonucleotides Picture
 Figure 2. Global CNS Specific Antisense Oligonucleotides Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global CNS Specific Antisense Oligonucleotides Market Share by Type: 2024 VS 2031
 Figure 4. Polyneuropathy Treatment Features
 Figure 5. Spinal Muscular Atrophy (SMA) Treatment Features
 Figure 6. Huntington’s Disease Treatment Features
 Figure 7. Global CNS Specific Antisense Oligonucleotides Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global CNS Specific Antisense Oligonucleotides Market Share by Application: 2024 VS 2031
 Figure 9. Hospital Pharmacies Case Studies
 Figure 10. Retail Pharmacies Case Studies
 Figure 11. Online Pharmacies Case Studies
 Figure 12. CNS Specific Antisense Oligonucleotides Report Years Considered
 Figure 13. Global CNS Specific Antisense Oligonucleotides Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global CNS Specific Antisense Oligonucleotides Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global CNS Specific Antisense Oligonucleotides Market Share by Region: 2024 VS 2031
 Figure 16. Global CNS Specific Antisense Oligonucleotides Market Share by Players in 2024
 Figure 17. Global Top CNS Specific Antisense Oligonucleotides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CNS Specific Antisense Oligonucleotides as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by CNS Specific Antisense Oligonucleotides Revenue in 2024
 Figure 19. North America CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America CNS Specific Antisense Oligonucleotides Market Share by Country (2020-2031)
 Figure 21. United States CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe CNS Specific Antisense Oligonucleotides Market Share by Country (2020-2031)
 Figure 25. Germany CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific CNS Specific Antisense Oligonucleotides Market Share by Region (2020-2031)
 Figure 33. China CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America CNS Specific Antisense Oligonucleotides Market Share by Country (2020-2031)
 Figure 41. Mexico CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa CNS Specific Antisense Oligonucleotides Market Share by Country (2020-2031)
 Figure 45. Turkey CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE CNS Specific Antisense Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Akcea Therapeutics, Inc. Revenue Growth Rate in CNS Specific Antisense Oligonucleotides Business (2020-2025)
 Figure 49. Ionis Pharmaceuticals Inc. Revenue Growth Rate in CNS Specific Antisense Oligonucleotides Business (2020-2025)
 Figure 50. Biogen Inc. Revenue Growth Rate in CNS Specific Antisense Oligonucleotides Business (2020-2025)
 Figure 51. Sarepta Therapeutics Revenue Growth Rate in CNS Specific Antisense Oligonucleotides Business (2020-2025)
 Figure 52. Wave Life Sciences Ltd. Revenue Growth Rate in CNS Specific Antisense Oligonucleotides Business (2020-2025)
 Figure 53. Dynacure Revenue Growth Rate in CNS Specific Antisense Oligonucleotides Business (2020-2025)
 Figure 54. ProQR Therapeutics N.V. Revenue Growth Rate in CNS Specific Antisense Oligonucleotides Business (2020-2025)
 Figure 55. Stroke Therapeutic Inc. Revenue Growth Rate in CNS Specific Antisense Oligonucleotides Business (2020-2025)
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Antisense Oligonucleotide Therapy for the Nervous System Market Research Report 2024
Global Oligonucleotide Therapeutics Market Research Report 2024
Global Antisense Oligonucleotides ASO Therapy Market Research Report 2024
Global Antisense Oligonucleotides based Therapeutics Market Research Report 2024
Global Oligonucleotide Oligo Drugs Market Research Report 2024
Global Oligonucleotide Therapy based Drug Market Research Report 2024
Global Oligonucleotide based Therapy Medicinal Product Market Research Report 2024
Global Antisense ODN Market Research Report 2024
Global Oligonucleotide Drug Delivery Market Research Report 2024
Antisense and RNAi Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antisense Oligonucleotides Market Research Report 2024
Global ASO based Drug Market Research Report 2024
Global Antisense Oligonucleotides ASOs Drugs Market Research Report 2024
Global Antisense Oligonucleotide Service Market Research Report 2025
Global Peptide and Oligonucleotide Drugs Market Research Report 2024
Antisense and RNAi Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oligonucleotide Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oligonucleotide based Therapies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oligonucleotide Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nucleic Acid Drugs Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions